|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.70 BDT | -0.83% |
|
-0.74% | +2.96% |
| Market Cap | 25.48B 206M 178M 167M 153M 288M 19.58B 292M 1.95B 767M 9.78B 772M 755M 32.56B | P/E 2024 |
68.2x | P/E 2025 | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 35.44B 286M 248M 232M 212M 401M 27.23B 406M 2.72B 1.07B 13.61B 1.07B 1.05B 45.29B | EV / Sales 2024 |
4.25x | EV / Sales 2025 | 2.74x |
| Free-Float |
36.94% | Yield 2024 |
1.3% | Yield 2025 | 1.98% |
| 1 day | -0.83% | ||
| 1 week | -0.74% | ||
| Current month | -0.74% | ||
| 1 month | -5.77% | ||
| 3 months | +3.26% | ||
| 6 months | +3.06% | ||
| Current year | +2.96% |
| 1 week | 107.4 | 110.2 | |
| 1 month | 107 | 117 | |
| Current year | 96 | 117.9 | |
| 1 year | 96 | 147.5 | |
| 3 years | 92.4 | 288.9 | |
| 5 years | 92.4 | 393 | |
| 10 years | 16 | 393 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ulfat Karim
CEO | Chief Executive Officer | - | - |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | - | |
| Director/Board Member | 42 | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.83% | -0.74% | -4.52% | -56.04% | 201M | ||
| +1.89% | +3.20% | +59.70% | +165.18% | 1,062B | ||
| -0.24% | +0.45% | +50.64% | +52.02% | 619B | ||
| -0.95% | -5.26% | +24.23% | +65.08% | 431B | ||
| 0.00% | +3.20% | +46.70% | +37.60% | 358B | ||
| +0.58% | -1.26% | +35.52% | +40.54% | 293B | ||
| -1.55% | -6.84% | +7.20% | +8.62% | 247B | ||
| -0.73% | +4.44% | +42.22% | +66.41% | 219B | ||
| -0.24% | -11.27% | +1.42% | -44.69% | 200B | ||
| -0.68% | -0.32% | +18.66% | +66.32% | 162B | ||
| Average | -0.55% | -1.78% | +28.18% | +40.10% | 359.25B | |
| Weighted average by Cap. | -0.54% | -0.83% | +40.83% | +77.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.7B 86.32M 74.91M 70.14M 64.16M 121M 8.22B 123M 821M 322M 4.11B 324M 317M 13.67B | 12.54B 101M 87.79M 82.21M 75.2M 142M 9.64B 144M 962M 377M 4.81B 380M 372M 16.03B |
| Net income | 521M 4.2M 3.65M 3.41M 3.12M 5.9M 400M 5.97M 39.95M 15.68M 200M 15.78M 15.44M 666M | 947M 7.63M 6.63M 6.2M 5.67M 10.71M 727M 10.85M 72.58M 28.48M 363M 28.66M 28.04M 1.21B |
| Net Debt | 10B 80.63M 69.97M 65.52M 59.94M 113M 7.68B 115M 767M 301M 3.84B 303M 296M 12.77B | 9.96B 80.36M 69.74M 65.3M 59.74M 113M 7.66B 114M 764M 300M 3.82B 302M 295M 12.73B |
Employees
4,771
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | BDT 107.70 | -0.83% | 122,825 |
| 04/08/26 | BDT 108.60 | 0.00% | 183,925 |
| 03/08/26 | BDT 108.60 | +0.09% | 155,831 |
| 02/08/26 | BDT 108.50 | 0.00% | 106,204 |
| 30/07/26 | BDT 108.50 | +0.28% | 197,132 |
- Stock Market
- Stocks
- BEACONPHAR Stock
Select your edition
All financial news and data tailored to specific country editions
















